Retrovir (zidovudine) may now be used twice daily in HIV-positive children ages six weeks to 18 years and can be dosed by weight, according to an announcement by the United States Food and Drug Administration (FDA).
Until now, the FDA recommended Retrovir three times a day in infants, children and adolescents, with the proper dose calculated by the total body surface area of the child.
The new dosing recommendations may be applied to either the syrup or tablet formulations of Retrovir.
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
"I am psychologically suffering from body wasting, mainly hips, face, legs and arms. Does anyone know where I can order something (maybe underwear with foam) to fill the sunken hips, so that pants can start looking normal? I feel pathetic when I look at myself in the mirror in jeans—jeans used to fill up so nicely, now they just hang!"
